Paula Cannon

Paula Cannon is a Professor at the University of Southern California, holding joint appointments in the Keck School of Medicine and Viterbi School of Engineering. Her research focuses on gene editing technologies like CRISPR/Cas9 to engineer immune cells for treating HIV, cancer, and chronic diseases. She serves as Associate Director of Cross School Programs for the MESH Academy and Special Advisor to the Provost.

• University of Liverpool (PhD)
• Harvard University (Postdoctoral)
• Oxford University (Postdoctoral)

Dr. Cannon's work spans Gene Editing, Immunology, and Biomedical Engineering, with recent emphasis on engineering B cells to produce non-natural antibodies. Her publications highlight advancements in AAV vectors, HIV latency, and SARS-CoV-2 research, reflecting interdisciplinary applications of genome editing.

She leads the Cannon Lab and contributes to institutional leadership as part of the MESH Academy and Provost office.